Calendar

pharmadog

Date TBD

RECRUITINGphase readoutNCT00756665: Prostate Active Surveillance Study

Sponsor: University of Washington. Phase: . Conditions: Prostatic Neoplasms

full page →ctgov ↗

COMPLETEDphase readoutNCT07500467: Upadacitinib for Refractory Takayasu Arteritis

Sponsor: Liu Tian. Phase: . Conditions: Takayasu Arteritis

full page →ctgov ↗

COMPLETEDphase readoutNCT04681807: Social Cognition in Youth Who Have a First Degree Relative With Schizophrenia

Sponsor: The Royal Ottawa Mental Health Centre. Phase: NA. Conditions: Schizophrenia

full page →ctgov ↗

COMPLETEDphase readoutNCT04993807: Data-driven SDM to Reduce Symptom Burden in AF

Sponsor: Columbia University. Phase: NA. Conditions: Atrial Fibrillation, Patient Engagement

full page →ctgov ↗

RECRUITINGphase readoutNCT06442592: Characterization and Support for Neurodevelopmental Disorders Associated With Congenital Heart Defects

Sponsor: Nantes University Hospital. Phase: NA. Conditions: Congenital Heart Defects, Neurodevelopmental Disorder

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06332092: FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma

Sponsor: Fulgent Pharma LLC.. Phase: PHASE2. Conditions: Head and Neck Squamous Cell Carcinoma

full page →ctgov ↗

RECRUITINGphase readoutNCT07455136: A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury

Sponsor: Hoffmann-La Roche. Phase: . Conditions: Traumatic Brain Injury

full page →ctgov ↗

COMPLETEDphase readoutNCT06953336: Vouchers for Improving Transplant Access to Lifestyle Nutrition - Kidney Transplant

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Food Insecurity, Kidney Transplant

full page →ctgov ↗

RECRUITINGphase readoutNCT05361811: Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial

Sponsor: National Cancer Institute (NCI). Phase: NA. Conditions: Neurofibromatosis 1, Noonan Syndrome, Legius Syndrome, Cardiofaciocutaneous Syndrome, Costello Syndrome

full page →ctgov ↗

RECRUITINGphase readoutNCT07282171: A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Participants With Preterm Preeclampsia and Their Children up to 24 Months

Sponsor: Comanche Biopharma. Phase: PHASE1. Conditions: sFlt1 Mediated Preterm Preeclampsia, Preeclampsia, Preterm Preeclampsia

full page →ctgov ↗

RECRUITINGphase readoutNCT06738771: Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa

Sponsor: Centre Hospitalier Régional d'Orléans. Phase: . Conditions: Pseudomonas Infections, Pseudomonas Aeruginosa, Prognosis, Drug Resistance, Multiple, Bacterial, Antibacterial Agents, Beta-lactam Antibiotics

full page →ctgov ↗

COMPLETEDphase readoutNCT04314544: Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)

Sponsor: Sun Pharmaceutical Industries Limited. Phase: PHASE3. Conditions: Active Psoriatic Arthritis

full page →ctgov ↗

RECRUITINGphase readoutNCT07195864: Retrospective Chart Review of Patients With Acanthamoeba Keratitis Who Have Received 0.8 mg/mL Polihexanide as Part of the "Medicines in Special Situations" (Medicamentos en Situaciones Especiales) Program in Spain.

Sponsor: SIFI SpA. Phase: . Conditions: Acanthamoeba Keratitis

full page →ctgov ↗

RECRUITINGphase readoutNCT05786664: Breast Cancer Survivorship Biorepository

Sponsor: University of Southern California. Phase: . Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Invasive Breast Carcinoma

full page →ctgov ↗

RECRUITINGphase readoutNCT07320209: Physiological and Neurocognitive Responses to Multisensory Food Cues in VR

Sponsor: Marmara University. Phase: NA. Conditions: Healthy Participants

full page →ctgov ↗

COMPLETEDphase readoutNCT07609732: Outcomes of Conventional Root Canal Treatment Compared to Regenerative Endodontics, and Cleaning and Shaping Only in Mature Upper First Premolars

Sponsor: Ain Shams University. Phase: NA. Conditions: Regenerative Endodontic Treatment, Cleaning and Shaping Only With Proper Coronal Seal, Necrotic Mature First Premolar

full page →ctgov ↗

RECRUITINGphase readoutNCT07398898: Use of Augmented Reality Glasses and Noise-Cancelling Headphones to Reduce Dental Anxiety in Adult Patients

Sponsor: Medical University of Warsaw. Phase: NA. Conditions: Dental Anxiety, Music Therapy, Oral Surgical Procedures

full page →ctgov ↗

RECRUITINGphase readoutNCT07424963: Hepatic Venous Pressure Gradient Versus Endoscopic Ultrasound-Guided Portal Pressure Gradient - Comparative Analysis (HEPCA)

Sponsor: Military University Hospital, Prague. Phase: NA. Conditions: Cirrhosis, Portal Hypertension, EUS, Non-Cirrhotic Portal Hypertension, HVPG, Hepatic Venous Pressure Gradient

full page →ctgov ↗

RECRUITINGphase readoutNCT03571763: The Impact of Anti-thrombosis on Cerebral Microbleeds and Intracranial Hemorrhage in Ischemic Stroke Patients

Sponsor: General Hospital of Shenyang Military Region. Phase: . Conditions: Ischemic Stroke

full page →ctgov ↗

COMPLETEDphase readoutNCT05352893: Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPP

Sponsor: Vanda Pharmaceuticals. Phase: PHASE3. Conditions: Generalized Pustular Psoriasis

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT02641093: Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma

Sponsor: Trisha Wise-Draper. Phase: PHASE2. Conditions: Head and Neck Cancer

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07334821: Diagnostic Performance of PIC Cystogram vs VCUG in Children

Sponsor: Tarik Emre Sener. Phase: NA. Conditions: Pediatric Urology

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07494721: Effects of Training With a Pressure Cuff on Cellular Energy Activity

Sponsor: Spital Thurgau AG. Phase: NA. Conditions: Physical Deconditioning

full page →ctgov ↗

COMPLETEDphase readoutNCT05425316: Speech in Hepatic Encephalopathy (HE)

Sponsor: University of Michigan. Phase: . Conditions: Hepatic Encephalopathy

full page →ctgov ↗

COMPLETEDphase readoutNCT01787500: Vemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: BRAF NP_004324.2:p.V600X, KRAS wt Allele, Metastatic Malignant Solid Neoplasm, Stage IV Colorectal Cancer AJCC v7, Stage IVA Colorectal Cancer AJCC v7, Stage IVB Colorectal Cancer AJCC v7, Unresectable Solid Neoplasm

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04739800: Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Fallopian Tube Mucinous Adenocarcinoma, Ovarian Seromucinous Carcinoma, Platinum-Refractory Fallopian Tube Carcinoma, Platinum-Refractory Ovarian Carcinoma, Platinum-Refractory Primary Peritoneal Carcinoma, Recurrent Fallopian Tube Clear Cell Adenocarcinoma, Recurrent Fallopian Tube Endometrioid Adenocarcinoma, Recurrent Fallopian Tube High Grade Serous Adenocarcinoma, Recurrent Fallopian Tube Mucinous Adenocarcinoma, Recurrent Fallopian Tube Transitional Cell Carcinoma, Recurrent Fallopian Tube Undifferentiated Carcinoma, Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma, Recurrent Ovarian Clear Cell Adenocarcinoma, Recurrent Ovarian Endometrioid Adenocarcinoma, Recurrent Ovarian High Grade Serous Adenocarcinoma, Recurrent Ovarian Low Grade Serous Adenocarcinoma, Recurrent Ovarian Mucinous Adenocarcinoma, Recurrent Ovarian Seromucinous Carcinoma, Recurrent Ovarian Transitional Cell Carcinoma, Recurrent Ovarian Undifferentiated Carcinoma, Recurrent Platinum-Resistant Fallopian Tube Carcinoma, Recurrent Platinum-Resistant Ovarian Carcinoma, Recurrent Platinum-Resistant Primary Peritoneal Carcinoma, Recurrent Primary Peritoneal Clear Cell Adenocarcinoma, Recurrent Primary Peritoneal Endometrioid Adenocarcinoma, Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma, Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma, Recurrent Primary Peritoneal Transitional Cell Carcinoma, Recurrent Primary Peritoneal Undifferentiated Carcinoma, Refractory Fallopian Tube Clear Cell Adenocarcinoma, Refractory Fallopian Tube Endometrioid Adenocarcinoma, Refractory Fallopian Tube High Grade Serous Adenocarcinoma, Refractory Fallopian Tube Mucinous Adenocarcinoma, Refractory Fallopian Tube Transitional Cell Carcinoma, Refractory Fallopian Tube Undifferentiated Carcinoma, Refractory Low Grade Fallopian Tube Serous Adenocarcinoma, Refractory Ovarian Clear Cell Adenocarcinoma, Refractory Ovarian Endometrioid Adenocarcinoma, Refractory Ovarian High Grade Serous Adenocarcinoma, Refractory Ovarian Low Grade Serous Adenocarcinoma, Refractory Ovarian Mucinous Adenocarcinoma, Refractory Ovarian Seromucinous Carcinoma, Refractory Ovarian Transitional Cell Carcinoma, Refractory Ovarian Undifferentiated Carcinoma, Refractory Primary Peritoneal Clear Cell Adenocarcinoma, Refractory Primary Peritoneal Endometrioid Adenocarcinoma, Refractory Primary Peritoneal High Grade Serous Adenocarcinoma, Refractory Primary Peritoneal Low Grade Serous Adenocarcinoma, Refractory Primary Peritoneal Transitional Cell Carcinoma, Refractory Primary Peritoneal Undifferentiated Carcinoma

COMPLETEDphase readoutNCT06733207: Pupillometry Use & Professional's Inspection : Leveling Subjectivity

Sponsor: CHU de Reims. Phase: . Conditions: Intensive Care, Pupil Assessment, Pupillometry, Neurological Examination, Clinical Competence, Nursing Assessment, Diagnostic Techniques and Procedures, Comparative Effectiveness Research, Interprofessional Relations, Observer Variation

full page →ctgov ↗

RECRUITINGphase readoutNCT07237607: Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders

Sponsor: Milton S. Hershey Medical Center. Phase: NA. Conditions: Eating Disorders, Anorexia Nervosa, Bulimia Nervosa, Binge-Eating Disorder

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07170592: A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients

Sponsor: Bionoxx Inc.. Phase: PHASE1. Conditions: Treatment-Refractory Solid Tumors

full page →ctgov ↗

RECRUITINGphase readoutNCT07621692: Exploring Auger-Enhanced PSMA-Targeted Radioligand Therapy: A First-in-Taiwan Clinical Study of 161Tb-PSMA-I&T

Sponsor: National Taiwan University Hospital. Phase: PHASE1. Conditions: Metastatic Castration Resistant Prostate Cancer (mCRPC)

full page →ctgov ↗

COMPLETEDphase readoutNCT07257692: Effect of Feeding Status on Appetite and Eating Behaviour.

Sponsor: University of Glasgow. Phase: NA. Conditions: Healthy

full page →ctgov ↗

RECRUITINGphase readoutNCT07058792: Impact of Medjool Date Consumption on Labor and Delivery Outcomes

Sponsor: The Cleveland Clinic. Phase: NA. Conditions: Spontaneous Labor

full page →ctgov ↗

RECRUITINGphase readoutNCT05258292: Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes

Sponsor: Institut de Recherches Cliniques de Montreal. Phase: . Conditions: Type1diabetes

full page →ctgov ↗

RECRUITINGphase readoutNCT06733636: Scents of Progress: Leveraging a Novel Device for Olfactory Training in Older Adults

Sponsor: Johns Hopkins University. Phase: NA. Conditions: Olfactory Dysfunction, Smell Loss, Anosmia, Hyposmia

full page →ctgov ↗

TERMINATEDphase readoutNCT05710536: Safety and Efficacy of Formulation for Improving Vagina Laxity: A Pilot Study

Sponsor: USMARI Research & Innovation Centre. Phase: NA. Conditions: Healthy

full page →ctgov ↗

COMPLETEDphase readoutNCT06662136: The Effect of Motivational Interviewing on HPV-DNA Testing

Sponsor: Muazez küçükkaya. Phase: NA. Conditions: Cervical Cancers

full page →ctgov ↗

RECRUITINGphase readoutNCT07521436: Awareness of Risk Factors and Perception of Cardiovascular Risk in Secondary Prevention Among Women and Men

Sponsor: Istituti Clinici Scientifici Maugeri SpA. Phase: . Conditions: Cardiovascular Disease

full page →ctgov ↗

RECRUITINGphase readoutNCT06813911: Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Sponsor: Novartis Pharmaceuticals. Phase: PHASE3. Conditions: Atherosclerotic Cardiovascular Disease (ASCVD)

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06608511: Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers

Sponsor: University of Wisconsin, Madison. Phase: . Conditions: Skin Cancer, Melanoma (Skin Cancer), Basal Cell Carcinoma of Skin, Basal Cell Carcinoma of Skin, Site Unspecified, Cutaneous Squamous Cell Carcinoma (CSCC), Merkel Cell Carcinoma of Skin

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07377071: Folate Treatment to Reduce Death Risk in the Year After Infection-Related Acute Kidney Injury

Sponsor: The University of Hong Kong. Phase: EARLY_PHASE1. Conditions: Infection-Associated Acute Kidney Injury

full page →ctgov ↗

RECRUITINGphase readoutNCT05640271: Tocilizumab for Acute Chest Syndrome

Sponsor: University of Chicago. Phase: PHASE2. Conditions: Sickle Cell Disease, Acute Chest Syndrome

full page →ctgov ↗

COMPLETEDphase readoutNCT07585344: Interrupted 'Figure-of-X' Versus Continuous Suturing Technique for Abdominal Wall Closure in Colorectal Laparotomies

Sponsor: Islamabad Medical and Dental College. Phase: NA. Conditions: Colorectal Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT06801834: Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

Sponsor: Gilead Sciences. Phase: PHASE3. Conditions: Extensive Stage Small Cell Lung Cancer (ES-SCLC)

full page →ctgov ↗

COMPLETEDphase readoutNCT04967664: Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery

Sponsor: Averitas Pharma, Inc.. Phase: PHASE3. Conditions: Post Surgical Neuropathic Pain

full page →ctgov ↗

RECRUITINGphase readoutNCT07571109: AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Sponsor: Novo Nordisk A/S. Phase: PHASE3. Conditions: Obesity, Overweight, Obstructive Sleep Apnoea

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07371871: A Prospective, Single-arm, Exploratory Study of Trifluridine/Tipiracil (TAS-102) Combined With Apatinib as Third-line Therapy for Advanced Gastric Cancer

Sponsor: Anhui Provincial Cancer Hospital. Phase: NA. Conditions: Advanced Gastric Cancer

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07544498: XR2ESILIENCE - XR-Based Resilience Training for Stress and Mental Health in Healthcare Workers

Sponsor: Medical University of Graz. Phase: NA. Conditions: Occupational Stress, Work-Related Stress, Mental Health, Burnout, Resilience

full page →ctgov ↗

COMPLETEDphase readoutNCT07565298: Adding Group-Based Pain Neuroscience Education to a Community Exercise Program for Older Women With Knee Osteoarthritis

Sponsor: Pontificia Universidad Catolica de Chile. Phase: NA. Conditions: Knee Osteoarthritis, Older Women, Pain, Disability

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT07381998: Effects of Total Thyroid Removal on Parathyroid Function and Quality of Life

Sponsor: Aarhus University Hospital. Phase: NA. Conditions: Hypoparathyroidism Post-surgical, Quality of Life

full page →ctgov ↗

RECRUITINGphase readoutNCT06958198: A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine)

Sponsor: University of Oxford. Phase: PHASE1. Conditions: Malaria,Falciparum

full page →ctgov ↗

Date TBD